Treatment with biologics does not increase the risk of a second malignancy in rheumatoid arthritis patients who have a history of cancer, according to new research findings presented this week at the 2017 ACR/ARHP Annual ...
Nov 5, 2017
0
0
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that hydroxychloroquine, an antimalarial drug and mainstay therapy for lupus, does not appear to be associated ...
Nov 1, 2021
0
1
The Food and Drug Administration (FDA) has released a draft guidance on biosimilar interchangeability titled "Considerations in Demonstrating Interchangeability With a Reference Product" that leaders at the American College ...
Jan 18, 2017
0
0
A newly developed tool to analyze the cellular and molecular profiles of synovial tissue and peripheral blood may help unlock clues about rheumatoid arthritis and lead to better therapies, according to new research findings ...
Nov 5, 2017
0
1
A new method for acquiring viable cells from cryopreserved tissue samples could provide researchers with a model for collecting and analyzing samples from different study sites to conduct more centralized research, according ...
Nov 5, 2017
0
1
Physician and healthcare professional advocates from the American College of Rheumatology (ACR) are joined by rheumatology patients on Capitol Hill this week to urge lawmakers to address the significant drug cost and access ...
Sep 26, 2017
0
1
Using a biologic therapy to manage rheumatoid arthritis may not significantly increase an infant's risk for developing opportunistic infections like pneumonia, meningitis, and tuberculosis, according to new research findings ...
Nov 5, 2017
0
0
In virtual meetings with lawmakers and on Twitter tomorrow, physician and health professional leaders from the American College of Rheumatology (ACR) are sounding the alarm about the economic impact of COVID-19 on rheumatology ...
May 21, 2020
0
0
